EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Idiopathic Recurrent Pregnancy Loss related toGPIagenein Iraqi patient women

Shuhala'J. M. Jawad, Raghad Kamel Taima

Medical and Pharmaceutical Journal · 2023

DOI: 10.55940/medphar202326 ↗
AbstractBibliografische Angaben

Abstract

Background: Recurrent pregnancy loss (RPL) is a major concern in the field of reproductive medicine. In particular, idiopathic recurrent pregnancy loss (iRPL) is a condition in which recurrent pregnancy loss occurs without a known cause. Recent studies have shown that genetic factors may contribute to iRPL, and the presence of the 807C/T silent polymorphisms in the GPIa gene has been associated with a higher risk of thrombosis and recurrent abortion.Aim: to determine the allelic frequency of GPIa 807C/T in patients with iRPL and healthy controls in Iraq.Material and Method: A T-ARMS PCR-based method was used to analyze the allelic frequency of GPIa 807C/T in 25 patients with iRPL and 25 healthy controls. The genotypic and allelic frequencies were calculated, and a statistical analysis was performed.Result: The results of this study showed that the allelic frequency for 807C was 48% and 46% in the patient and control groups, respectively. The allelic frequency of 807T was recorded as 52% in the patient group, whereas the control group showed 54%. The patient group's genotypic frequencies were distributed as 16% for 807TT, 12% for 807CC, and 72% for 807CT. On the other hand, the control group reported genotypic frequencies of 32% for 807TT, 24% for 807CC, and 44% for 807CT. Interestingly, the TC heterozygous genotype of the GPIa gene's 807C\T showed a significant increase (P ≤ 0.05) with a risk (OR=3.27) in the patient group against the control.Conclusion: the results of this study suggest that the presence of the GPIa 807C/T polymorphism is associated with a higher risk of iRPL in Iraqi patient women. The findings of this study could be used to develop new diagnostic and therapeutic strategies for iRPL.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →